Implementing a Methadone Delivery System in New York City in Response to COVID-19

Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation...

Full description

Saved in:
Bibliographic Details
Published in:American journal of public health (1971) 2021-12, Vol.111 (12), p.2115-2117
Main Authors: Harocopos, Alex, Nolan, Michelle L, Goldstein, Gail P, Mantha, Shivani, O'Neill, Madeleine, Paone, Denise
Format: Article
Language:English
Subjects:
Adult
Clinical medicine
Collaboration
Communicable Disease Control - organization & administration
Comorbidity
Coronaviruses
COVID-19
COVID-19 - epidemiology
Drug addiction
Drugs
Female
Fentanyl
Flexibility
Health Service Delivery
Hotels & motels
Humans
Illnesses
Lockboxes
Male
Mental health
Methadone
Methadone - administration & dosage
Methadone - therapeutic use
Middle Aged
Narcotics
New York City - epidemiology
Notes From the Field
Opiate Substitution Treatment - methods
Opinions, Ideas, & Practice
Opioid-Related Disorders - drug therapy
Opioids
Overdose
Pandemics
Patients
Program Evaluation
Public health
Quarantine
Risk reduction
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Substance use disorder
Telemedicine
Telemedicine - organization & administration
Toxicology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. ( . 2021;111(12):2115-2117. https://doi.org/10.2105/AJPH.2021.306523).
ISSN:0090-0036
1541-0048
DOI:10.2105/AJPH.2021.306523